Genkyotex
Signal active
Organization
Contact Information
Overview
Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage. Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
About
Industries
Biotechnology, Health Care, Pharmaceutical
Founded
2006
Employees
11-50
Headquarters locations
Geneva, Geneve, Switzerland, Europe
Social
Profile Resume
Genkyotex headquartered in Switzerland, Europe, operates in the Biotechnology, Health Care, Pharmaceutical sector. The company focuses on Biotechnology and has secured $8.4B in funding across 96 round(s). With a team of 11-50 employees, Genkyotex is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Genkyotex, raised $4.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
1
Lead Investors
0
Total Funding Amount
$87.1M
Details
5
Genkyotex has raised a total of $87.1M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2012 | Late Stage Venture | 25.6M | ||
| 2011 | Late Stage Venture | 20.4M | ||
| 2006 | Seed | 1.6M | ||
| 2008 | Early Stage Venture | 4.0M |
Investors
Genkyotex is funded by 40 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Genkyotex | - | FUNDING ROUND - Genkyotex | 1.6M |
| Eclosion SA | - | FUNDING ROUND - Eclosion SA | 1.6M |
| Genkyotex | - | FUNDING ROUND - Genkyotex | 4.0M |
| Societe Generale Asset Management | - | FUNDING ROUND - Societe Generale Asset Management | 4.0M |
Recent Activity
News
Jul 26, 2022
Google Patent - Immunogenic composition comprising cyaa-derived polypeptide promoting a th1/ …
Funding Round
Feb 06, 2020
Genkyotex raised $5380790 on 2020-02-06 in Post-IPO Equity
Funding Round
Aug 21, 2018
Genkyotex raised $8681993 on 2018-08-21 in Post-IPO Equity
Funding Round
Jan 07, 2015
Genkyotex raised $19742206 on 2015-01-07 in Post-IPO Equity
Funding Round
Jul 09, 2012
Genkyotex raised $25600852 on 2012-07-09 in Series C
Funding Round
May 24, 2011
Genkyotex raised $20400000 on 2011-05-24 in Series C